“…Pt(II) has a strong thermodynamic preference for binding to S-donor ligands. For that reason, one would predict that platinum compounds would perhaps never reach DNA, with many cellular platinophiles (S-donor ligands, such as glutathione, methionine) as competing ligands in the cytosol [3,4]. Despite the success of cisplatin, however, it lacks selectivity for tumor tissue, which leads to severe side effects.…”